摘要
α、β和γ3种分泌酶是淀粉样前体蛋白(APP)加工及代谢的关键酶,选择性地激活α分泌酶或抑制β和γ分泌酶,将有助于减少β-淀粉样蛋白(Aβ)的产生,并可能成为治疗AD的有效靶点。该文主要对APP 3种分泌酶活性表达的影响因素及其靶向干预研究的进展做一综述。
α,β and γ secretases are three kinds of key enzymes in processing and metabolizing amyloid precursor protein(APP).Their selective activation of the α secretase or inhibition of β and γ secretase will help reduce the production of β-amyloid protein(Aβ),and may become one of the effective targets to treating AD.This paper aims to make a review on the research development of relevant factors influencing the activity and expression of 3 APP secretases and their targeted intervention in pharmaceutical studies.
出处
《中国药理学通报》
CAS
CSCD
北大核心
2011年第10期1349-1353,共5页
Chinese Pharmacological Bulletin
基金
浙江省科技计划资助项目(No2007C23021)
浙江省研究生创新科研资助项目(No71015111)
浙江省新苗人才计划资助项目(No2010R410016)
关键词
阿尔采末病
Β-淀粉样前体蛋白
分泌酶
靶向干预
激动剂
抑制剂
机制
Alzheimer's disease
amyloid precursor protein
secretase
targeted intervention
agonist
inhibitor
mechanism